<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>生物制药小编 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-21T11:22:31+08:00</updated>
  <subtitle>“新起点，再出发”——生物医药小编与您共同关注生物制药行业热点。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>游方和尚专栏 | 药代动力学的重要概念和方法（二_上）：药物的血浆末端半衰期</title>
    <updated>2020-12-20T12:36:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/D-esK3KngrwVxNJm4Y3pNg</id>
    <link href="https://mp.weixin.qq.com/s/D-esK3KngrwVxNJm4Y3pNg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年FDA批准上市的抗癌新药/适应症</title>
    <updated>2020-12-20T12:36:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/JNi5WGSJvBrRGzFV7Mjf3A</id>
    <link href="https://mp.weixin.qq.com/s/JNi5WGSJvBrRGzFV7Mjf3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>c-Met靶点收获之际——盘点多类型药物的开发现状</title>
    <updated>2020-12-19T10:18:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/UJT4IyAMpw4wYULU1AvsUw</id>
    <link href="https://mp.weixin.qq.com/s/UJT4IyAMpw4wYULU1AvsUw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Roche 新型CD25抗体选择性清除调节性T细胞，增强抗肿瘤免疫</title>
    <updated>2020-12-18T17:32:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/4mQStGjfFcLrKi1ZqukAXQ</id>
    <link href="https://mp.weixin.qq.com/s/4mQStGjfFcLrKi1ZqukAXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>GITR激动剂单药尽数惨败，MEDI1873停止临床研究！</title>
    <updated>2020-12-18T17:32:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/YhgKSogJ4kp4Msd5-OYUaQ</id>
    <link href="https://mp.weixin.qq.com/s/YhgKSogJ4kp4Msd5-OYUaQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-Stem Cell：当CAR遇上Stem Cell</title>
    <updated>2020-12-17T19:32:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/as9nie2qs2rs3ctUaW84Eg</id>
    <link href="https://mp.weixin.qq.com/s/as9nie2qs2rs3ctUaW84Eg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅！NMPA正式受理HLX01（利妥昔单抗）类风湿关节炎新适应症的上市注册申请</title>
    <updated>2020-12-17T19:32:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-17:/s/OSZ7feknxBZR2IW7lO1AQw</id>
    <link href="https://mp.weixin.qq.com/s/OSZ7feknxBZR2IW7lO1AQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>洞悉需求，乘势而上，以创新助力生物药生产 | 专访登山者Eppendorf</title>
    <updated>2020-12-16T21:49:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-16:/s/KaWZHfhQ_8Qiu0RSSYAn3A</id>
    <link href="https://mp.weixin.qq.com/s/KaWZHfhQ_8Qiu0RSSYAn3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向双重肿瘤抗原（TAA）的双特异性抗体(BsAb)</title>
    <updated>2020-12-15T19:41:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-15:/s/a1EDmolt1FHftl4SXVaDlg</id>
    <link href="https://mp.weixin.qq.com/s/a1EDmolt1FHftl4SXVaDlg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>游方和尚专栏 | 药代动力学的重要概念和方法（一）：药物的清除率</title>
    <updated>2020-12-14T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/IsstATTglX2uHDgkOGfIQw</id>
    <link href="https://mp.weixin.qq.com/s/IsstATTglX2uHDgkOGfIQw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>十年沉浮，VEGF依旧受到追捧？</title>
    <updated>2020-12-14T21:14:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/-8EzV-_WwsGtZmHQc8sIIQ</id>
    <link href="https://mp.weixin.qq.com/s/-8EzV-_WwsGtZmHQc8sIIQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Bio-Empower 智驱未来 | 当在生物医药领域谈起AI和智能化</title>
    <updated>2020-12-14T09:23:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/Nw3ndbV6JDSzrRijhRhOpg</id>
    <link href="https://mp.weixin.qq.com/s/Nw3ndbV6JDSzrRijhRhOpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅会议】第七届中国生物制药峰会</title>
    <updated>2020-12-14T09:23:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/BB9d5P1PVvkuVh4OEskDjw</id>
    <link href="https://mp.weixin.qq.com/s/BB9d5P1PVvkuVh4OEskDjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>四大类Biomarker评价免疫检查点疗效</title>
    <updated>2020-12-14T09:23:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-14:/s/H_bV-1_gkjrOng3s86XaXg</id>
    <link href="https://mp.weixin.qq.com/s/H_bV-1_gkjrOng3s86XaXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向受体复合物，精准GPCRs药物开发策略</title>
    <updated>2020-12-12T13:45:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-12:/s/UuW47zol_98SAGFcTmqhYg</id>
    <link href="https://mp.weixin.qq.com/s/UuW47zol_98SAGFcTmqhYg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤Biomarker分解的DNA纳米凝胶用于靶向治疗：高效、低毒</title>
    <updated>2020-12-11T17:52:52+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/ppxfUd7QnKDmWoQS_m1ezA</id>
    <link href="https://mp.weixin.qq.com/s/ppxfUd7QnKDmWoQS_m1ezA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>